You are here

IPOs

With anti-VEGF challenger in clinic, Kodiak files for IPO

BioCentury

Mon, 09/10/18 - 12:19 am

Kodiak Sciences

Two more Peninsula IPOs tell the story of biotech's investment boom

Bizjournals.com

Sat, 09/8/18 - 11:43 pm

Guardant Health

Kodiak Sciences

Liquid biopsy company Guardant files for NASDAQ IPO

BioCentury

Thu, 09/6/18 - 07:25 pm

Guardant Health

Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO

Xconomy

Wed, 09/5/18 - 09:30 am

Fulcrum Therapeutics

Principia Sets IPO Terms as It Eyes Late-Stage Studies for Lead Drug

Xconomy

Tue, 09/4/18 - 11:06 pm

Principia Biopharma

Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs

Xconomy

Thu, 08/30/18 - 11:46 pm

Sutro BioPharma

The booming Boston/Cambridge biotech hub claims an industry-leading role — nobody beats it at raising record amounts of money

Endpoints

Wed, 08/29/18 - 11:07 pm

Second time lucky? Alzheon tries for much-reduced IPO

Fierce Biotech

Tue, 08/28/18 - 10:33 am

Alzheimer's disease

Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA

Xconomy

Tue, 08/28/18 - 10:20 am

pediatric cancer

AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

Endpoints

Mon, 08/20/18 - 10:11 am

Principia Biopharma

autoimmune disease

AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3

Fierce Biotech

Mon, 08/20/18 - 10:09 am

clinical trials

Samumed, a $12 billion startup that wants to cure baldness and smooth out your wrinkles, just raised even more funding as it plots an IPO

Business Insider

Tue, 08/7/18 - 12:08 am

wrinkle treatment

The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs

Yahoo/Benzinga

Sun, 08/5/18 - 07:25 pm

Pain Therapeutics

Vertex Pharmaceuticals

lumacaftor/ivacaftor

Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals

Xconomy

Fri, 08/3/18 - 11:02 pm

Drugmaker Lilly's Elanco animal health unit files for IPO

Yahoo/Reuters

Thu, 08/2/18 - 11:16 pm

BeiGene Proposes $800+ Million Offering

CP Wire

Fri, 07/27/18 - 11:50 am

Drugmaker Lilly plans IPO for part of animal health business

Yahoo/AP

Tue, 07/24/18 - 10:28 am

Urovant seeks $150M IPO just a year after launch

Fierce Biotech

Mon, 07/16/18 - 10:16 pm

Urovant Sciences

overactive bladder

A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

Endpoints

Mon, 07/16/18 - 09:11 am

Constellation Pharma

Crinetics Pharmaceuticals

Rubius Therapeutics

A roaring Rubius sets out to snag $1.8B market cap in $200M IPO

Endpoints

Mon, 07/9/18 - 11:22 am

Rubius Therapeutics

Pages